인적 번역의 예문에서 번역 방법 학습 시도.
전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
d phase ii and iii clinical studies.
operáciu dolných končatín ako je bedrová zlomenina, závažné operácie kolena alebo náhradu bedrového kĺbu.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
patient characteristics in phase ii and phase iii studies
charakteristika pacientov v štúdiách ii. fázy a iii. fázy
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
phase ii and iii studies phase iii phase iii vc dex
fáza iii vc
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
dosing regimens in phase ii and phase iii studies phase
dávkovací režim v štúdiách ii. fázy a iii. fázy fáza
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
patient exposure to treatment with velcade during phase ii and iii studies
expozícia pacientov liečbe s velcade v priebehu ii. a iii. fázy štúdií
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
over 4874 patients were studied in controlled phase ii and iii clinical studies.
v kontrolovaných klinických štúdiách fázy ii. a iii bolo sledovaných vyše 4 874 pacientov.
마지막 업데이트: 2017-04-26
사용 빈도: 6
품질:
over 4874 patients were studied in controlled phase ii and iii clinical studies. na
v kontrolovaných klinických štúdiách fázy ii. a iii bolo sledovaných vyše 4 874 pacientov.
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
incidences of adverse reactions and marked laboratory abnormalities from the phase ii and phase iii studies.
výskyt nežiaducich reakcií a výrazných laboratórnych odchýlok zo štúdií fázy ii a fázy iii.
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
dosing regimens in phase ii and phase iii studies phase/ arm treatment schedule
dávkovací režim v štúdiách ii. fázy a iii. fázy fáza
마지막 업데이트: 2012-04-12
사용 빈도: 2
품질:
cat ii and iii
cat ii a iii
마지막 업데이트: 2014-11-21
사용 빈도: 2
품질:
a total of 201 cushing’s disease patients received signifor in phase ii and iii studies.
celkovo 201 pacientov s cushingovou chorobou dostávalo signifor v klinických skúšaniach fázy ii a iii.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
annexes ii and iii
prílohy ii a iii
마지막 업데이트: 2017-04-06
사용 빈도: 6
품질:
appendix ii and iii.
dodatok ii a iii.
마지막 업데이트: 2014-11-21
사용 빈도: 4
품질:
sections ii and iii:
Časti ii a iii:
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
the phase ii trial, study yu203, randomised
Štúdia fázy ii, yu203, randomizovala
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
table 14: summary of disease outcomes from the phase iii (apex) and phase ii studies
tabuľka 13: výsledky účinnosti zo štúdie mmy-3010
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the phase ii and iii clinical studies involving 1,410 patients with ckd stage 5 on dialysis treated with bindren for up to one year constituted the safety population.
klinické štúdie fáza ii a iii zahŕňali 1 410 pacientov s choo, fáza 5, ktorí podstúpili dialýzu a užívali bindren až do jedného roka a ktorí vytvorili bezpečnú populáciu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
table 2 adverse drug reactions observed in the phase ii pivotal study
tabuľka 2 nežiaduce reakcie na liek pozorované v pivotnom klinickom skúšaní fázy ii
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
a responder analysis of the pivotal phase ii and iii studies showed significant improvements in all three major clinical endpoints versus placebo in patients on concomitant transdermal and oral non-cee estrogens.
analýza odozvy na liečbu v kľúčových štúdiách fázy ii a iii ukázala významné zlepšenia vo všetkých troch hlavných klinických cieľoch liečby v porovnaní s placebom u pacientok, ktoré súbežne transdermálne a perorálne používali iné estrogény ako cee.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
in the phase ii and iii uc studies through week 54, antibodies to golimumab were detected by the eia method in 3% (26/946) of golimumab treated patients.
vo fáze ii a iii štúdií s uc boli až do 54. týždňa použitím metódy eia zistené protilátky proti golimumabu u 3 % (26/946) pacientov liečených golimumabom.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: